Adaptin Bio
- Biotech or pharma, therapeutic R&D
Adaptin Bio, Inc. is a biotechnology company developing novel therapies for central nervous system disorders utilizing proprietary technologies for improved drug delivery to the brain and other tissues. The company’s proprietary Brain Bispecific T cell Engager (BRiTE) technology was developed by researchers at the Department of Neurosurgery at Duke University. The company’s mission is to develop novel therapies to improve patient outcomes in difficult-to-treat CNS diseases.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}